8 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
inhibitors in CVD ... HF outcomes in HFrEF ... HF outcomes in HFrEF ... visualabstract #table #CVD ... #CKD
Oral Antihypertensive Medications - Selection by Comorbidities
Comorbidities: 
 • Stable Angina, HFpEF, HFrEF, AFib, TAA/Marfan, Aortic
Antihypertensive Medications ... Stable Angina, HFpEF ... , HFrEF, AFib, TAA ... Dissection • CKD ... pharmacology #table #management
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
angiotensin-receptor blocker; CAD ... ejection fraction; GDMT ... failure; HFpEF, ... ejection fraction; HFrEF ... quality of life; HTN
Guideline-Directed Medical Therapy (GDMT) in HFrEF and CKD

 • Class I pillars of HFrEF GDMT across
) in HFrEF and CKD ... therapies" for HFrEF ... Chronotropes • Medications ... used in HFrEF: ... #CKD #HFrEF #management
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Heart Failure (HFrEF ... Ejection Fraction (HFrEF ... patients with HFrEF ... #HeartFailure #HFrEF ... #Pharmacology #Management
Intern Pocket Cards - Inpatient Blood Pressure Management Guide
ß-blockers:
 • Metoprolol, Carvedilol, Labetalol
 • Bradycardia, heart
Blood Pressure Management ... Amlodipine • HFrEF ... pocketcardset #HTN ... BloodPressure #medications ... pharmacology #table #agents
HFpEF and CAD Management Algorithm
1. Consider revascularization based on current guidelines for CAD and HFpEF*
2. Statins:
HFpEF and CAD Management ... guidelines for CAD ... and HFpEF* 2. ... Enroll in HFpEF ... #CAD #Management
Causes of Secondary Hypertension - Workup and Differential Diagnosis
Approach (when evaluation should be done):
1. Severe or
antihypertensive agents ... or papilledema, heart ... parenchymal disease: CKD ... most pts have HTN ... Differential #Diagnosis #indications